A rare form of systemic amyloidosis with kidney damage — AFIB-amyloidosis
https://doi.org/10.21886/2712-8156-2023-4-1-106-112
Abstract
Within the framework of this publication, the first description of the AFib-form of amyloidosis with kidney damage in the Russian Federation is presented. Detection of a rare form of amyloidosis became possible after morphological examination of the kidneys and typing of amyloid into AA and AL forms, as well as mass spectrometric examination of the patient's blood and urine.
About the Authors
M. M. Batyushin
Rostov State Medical University
Russian Federation
Russian Federation
Mikhail Mikhailovich Batyushin, Professor, Dr. Sci. (Med.), Professor of the Department of Internal Diseases No. 2
Rostov-on-Don
L. R. Ablyakimova
Clinical Hospital "RZD-Medicine"
Russian Federation
Russian Federation
Ablyakimova Lera Rusikmovna, nephrologist
Bataysk
I. V. Sarvilina
Novomedicine Medical Center
Russian Federation
Russian Federation
Irina Vladislavovna Sarvilina, Professor, Dr. Sci. (Med.), Director
Rostov-on-Don
References
1. Benson M.D., Buxbaum J.N., Eisenberg D.S., Merlini G., Saraiva M.J.M., Sekijima Y. et al. Amyloid nomenclature 2018: recommendations by the International Society of Amyloidosis (ISA) nomenclature committee. Amyloid. 2018;25(4):215-219. doi: 10.1080/13506129.2018.1549825.
2. Nie P., Chen R., Luo M., Dong C., Chen L., Liu J. et al. Clinical and Pathological Analysis of 4910 Patients Who Received Renal Biopsies at a Single Center in Northeast China. Biomed Res Int. 2019;2019:6869179. doi: 10.1155/2019/6869179.
3. Nie P., Lou Y., Wang Y., Bai X., Zhang L., Jiang S. et al. Clinical and pathological analysis of renal biopsies of elderly patients in Northeast China: a single-center study. Ren. Fail. 2021;43(1):851–859. doi: 10.1080/0886022X.2021.1923527
4. Li Z.Y., Wang S., Li D.Y., Liu D., Wang S.X., Yu X.J. et al. Fibrinogen A Alpha-Chain Amyloidosis in Two Chinese Patients. Front Med (Lausanne). 2022;9:869409. doi: 10.3389/fmed.2022.869409.
5. Said S.M., Sethi S., Valeri A.M., Leung N., Cornell L.D., Fidler M.E. et al. Renal amyloidosis: origin and clinicopathologic correlations of 474 recent cases. Clin J Am Soc Nephrol. 2013;8(9):1515-23. doi: 10.2215/CJN.10491012.
6. Benson M.D., Liepnieks J., Uemichi T., Wheeler G., Correa R. Hereditary renal amyloidosis associated with a mutant fibrinogen alpha-chain. Nat Genet. 1993;3:252–5. 10.1038/ng0393-252.
7. Weisel J.W., Litvinov R.I. Mechanisms of fibrin polymerization and clinical implications. Blood. 2013;121:1712–9. 10.1182/blood-2012-09-306639.
8. Yazaki M., Yoshinaga T., Sekijima Y., Kametani F., Okumura N. Hereditary fibrinogen aalpha-chain amyloidosis in Asia: clinical and molecular characteristics. Int J Molec Sci. 2018;19.10.3390/ijms19010320.
9. Gillmore J.D., Lachmann H.J., Rowczenio D., Gilbertson J.A., Zeng C.H., Liu Z.H. et al.. Diagnosis, pathogenesis, treatment, and prognosis of hereditary fibrinogen A alpha-chain amyloidosis. J Am Soc Nephrol. 2009;20:444–51. 10.1681/ASN.2008060614
10. Ihne S., Morbach C., Sommer C., Geier A., Knop S., Störk S. Amyloidosis-the Diagnosis and Treatment of an Underdiagnosed Disease. Dtsch Arztebl Int. 2020;117(10):159-166. doi: 10.3238/arztebl.2020.0159.
Supplementary files
Review
For citations:
Batyushin M.M., Ablyakimova L.R., Sarvilina I.V. A rare form of systemic amyloidosis with kidney damage — AFIB-amyloidosis. South Russian Journal of Therapeutic Practice. 2023;4(1):106-112. (In Russ.) https://doi.org/10.21886/2712-8156-2023-4-1-106-112
Views:
939
Email this article 